As the inaugural featured conference, The 1st CNS Innovative Drug R&D Conference is co-hosted by TONACEA, Hanshu Bio, and Quark Pharma. Focusing on the high-value, high-potential sector of CNS drug development, the conference brings together top R&D experts from around the world to decode emerging CNS targets and mechanisms, clinical development, gene editing, and other key technologies. It will feature in-depth discussions on cutting-edge topics such as the treatment of CNS diseases and global registration strategies for innovative drugs, aiming to establish a professional exchange platform for R&D innovation, clinical translation, industrial collaboration, and global partnership in the CNS field.

Blueprint for the Conference Unveiled! The Inaugural Global Summit on Innovative Drugs from Major Countries to Create a Chinese Version of JPM

Mar 22,2026

The conference is benchmarked against the J.P. Morgan Healthcare Conference, establishing a model of "China Innovation—Global Translation—Shanghai Exchange." It aims to highlight China's status as a major player in new drugs and drive Chinese innovation to lead the global health industry.

Zhu Xun: It’s Time for China’s Innovative Drugs to Shift from “R&D Stories” to “Profit Stories”

Mar 21,2026

The logic, challenges, and ways to break through the frenzy of going out to sea

< 1...23 24 25 26 > proceed page

Follow or Contact Us

Follow the TONACEA Official WeChat Account and scan the QR code to register. Stay updated with the latest conference news.

Public Account QR Code

Registration QR Code

Conference Service Hotline

+86 010 8363 4290

© 2026 TONACEA (Shanghai) Technology Development Co., Ltd. All rights reserved. All rights reserved.